1. Hu W, Fang L, Ni R et al. Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years. BMC Cancer 2022; 22: 836.
2.
Roland N, Memon A. Non-melanoma skin cancer of the head and neck. Br J Hosp Med 2023; 84: 1-10.
3.
Nazzaro G, Minuti A, Quattri E, Passoni E. Mohs micrographic surgery: the experience of the dermatology unit of the university of Milan confirms the superiority over traditional surgery in high-risk non-melanoma skin cancers. Dermatol Reports 2022; 15: 9532.
4.
Yu L, Moloney M, Tran A et al. Local control comparison of early-stage non-melanoma skin cancer (NMSC) treated by superficial radiotherapy (SRT) and external beam radiotherapy (XRT) with and without dermal image guidance: a meta-analysis. Discov Oncol 2022; 13: 129.
5.
Chouhan R, Patel R, Mitsimponas K. Surgical excision of non-melanoma skin cancer: no end in site? Br J Oral Maxillofac Surg 2019; 57: e100.
6.
Lai M, Pampena R, Mirra M et al. Characteristics and management of skin cancers in very elderly patients: A real-world challenge for clinicians. Exp Dermatol 2022; 31: 1554-1562.
7.
Kim JW, Yun BM, Shin MS et al. Effectiveness of radiotherapy for head and neck skin cancers: a single-institution study. Radiat Oncol J 2019; 37: 293-301.
8.
Griep C, Davelaar J, Scholten AN et al. Electron beam therapy is not inferior to superficial x-ray therapy in the treatment of skin carcinoma. Int J Radiat Oncol Biol Phys 1995; 32: 1347-1350.
9.
Köhler-Brock A, Prager W, Pohlmann S, Kunze S. The indications for and results of HDR afterloading therapy in diseases of the skin and mucosa with standardized surface applicators (the Leipzig applicator). Strahlenther Onkol 1999; 175: 170-174.
10.
Arenas M, Arguís M, Díez-Presa L et al. Hypofractionated high-dose-rate plesiotherapy in nonmelanoma skin cancer treatment. Brachytherapy 2015; 14: 859-865.
11.
Tagliaferri L, Ciardo FG, Fionda B et al. Non-melanoma skin cancer treated by contact high-dose-rate radiotherapy (brachytherapy): A mono-institutional series and literature review. In vivo 2021; 35: 2313-2319.
12.
Allan E, Stanton A, Pye D et al. Fractionated high dose rate brachytherapy moulds-a precise treatment for carcinoma of the pinna. Radiother Oncol 1998; 48: 277-281.
13.
Viswanathan AN, Petereit DG, Devlin PM. Brachytherapy: applications and technique. 2007; 223-267. https://doctorlib.org/therapy/brachytherapy/9.html
14.
Sen S, Bandyopadhyay A, Pal J et al. A dosimetric study of electron beam therapy vs. high-dose-rate mould brachytherapy in adjuvant treatment of non-melanoma skin carcinomas of the head and neck region. J Contemp Brachytherapy 2019; 11: 547-553.
15.
Gauden R, Pracy M, Avery AM et al. HDR brachytherapy for superficial non-melanoma skin cancers. J Med Imaging Radiat Oncol 2013; 57: 212-217.
16.
Delishaj D, Laliscia C, Manfredi B et al. Non-melanoma skin cancer treated with high-dose-rate brachytherapy and Valencia applicator in elderly patients: a retrospective case series. J Contemp Brachytherapy 2015; 7: 437-444.
17.
Safigholi H, Meigooni AS, Song WY. Comparison of 192Ir, 169Yb, and 60Co high-dose rate brachytherapy sources for skin cancer treatment. Med Phys 2017; 44: 4426-4436.
18.
Kalaghchi B, Esmati E, Ghalehtaki R et al. High-dose-rate brachytherapy in treatment of non-melanoma skin cancer of head and neck region: preliminary results of a prospective single institution study. J Contemp Brachytherapy 2018; 10: 115-122.
19.
Laliscia C, Fuentes T, Coccia N et al. High-dose-rate brachytherapy for non-melanoma skin cancer using tailored custom moulds – a single-centre experience. Contemp Oncol 2021; 25: 12-16.
20.
Maroñas M, Guinot JL, Arribas L et al. Treatment of facial cutaneous carcinoma with high-dose rate contact brachytherapy with customized molds. Brachytherapy 2011; 10: 221-227.
21.
Guix B, Finestres F, Tello J et al. Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds. Int J Radiat Oncol Biol Phys 2000; 47: 95-102.
22.
Montero A, Hernanz R, Capuz AB et al. High-dose-rate (HDR) plesiotherapy with custom-made moulds for the treatment of non-melanoma skin cancer. Clin Transl Oncol 2009; 11: 760-764.
23.
Cisek P, Kieszko D, Bilski M et al. Interstitial HDR brachytherapy in the treatment of non-melanocytic skin cancers around the eye. Cancers 2021; 13: 1425.
24.
Tagliaferri L, Giarrizzo I, Fionda B et al. ORIFICE (Interventional Radiotherapy for Face Aesthetic Preservation) Study: results of interdisciplinary assessment of interstitial interventional radiotherapy (brachytherapy) for periorificial face cancer. J Pers Med 2022; 12: 1038.
25.
Bilski M, Cisek P, Baranowska I et al. Brachytherapy in the treatment of non-melanoma skin peri-auricular cancers – a retrospective analysis of a single institution experience. Cancers 2022; 14: 5614.
26.
Chyrek AJ, Chicheł A, Burchardt WM et al. Superficial high-dose-rate brachytherapy for primary tumors and relapses after surgery in patients with basal cell carcinoma of the head and neck region: results of a retrospective comparative cohort study. J Contemp Brachytherapy 2022; 14: 438-445.
27.
Brovchuk S, Park SJ, Shepil Z et al. High-dose-rate skin brachytherapy with interstitial, surface, or a combination of interstitial and surface mold technique. J Contemp Brachytherapy 2022; 14: 107-114.
28.
Gebremariam TY, Geraily G, Jassim HH, Gholami S. Dosimetric comparison between microSelectron iridium-192 and flexi cobalt-60 sources in high-dose-rate brachytherapy using Geant4 Monte Carlo code. J Contemp Brachytherapy 2023; 15: 141-147.
29.
Sheikholeslami S, Khodaverdian S, Hashemzaei F et al. Evaluation of bone dose arising from skin cancer brachytherapy: A comparison between 192Ir and 60Co sources through Monte Carlo simulations. Comput Methods Programs Biomed 2021; 205: 106089.
30.
Strohmaier S, Zwierzchowski G. Comparison of (60)Co and (192)Ir sources in HDR brachytherapy. J Contemp Brachytherapy 2011; 3: 199-208.
31.
Buzurovic I, Mott JH, Perez-Catalayud J, Zuchora A. Medical physics and planning in skin radiotherapy and brachytherapy. Non-melanoma skin cancer. CRC Press 2023; 195-224.
32.
McGinley PH. Shielding techniques for radiation oncology facilities. J Appl Clin Med Phys 2002; 3: 261.
33.
Baltas D, Sakelliou L, Zamboglou N. The physics of modern brachytherapy for oncology. CRC Press 2006.
34.
Olek D, El-Ghamry MN, Deb N et al. Custom mold applicator high-dose-rate brachytherapy for nonmelanoma skin cancer – an analysis of 273 lesions. Brachytherapy 2018; 17: 601-608.
35.
Bielęda G, Chicheł A, Boehlke M et al. 3D printing of individual skin brachytherapy applicator: design, manufacturing, and early clinical results. J Contemp Brachytherapy 2022; 14: 205-214.
36.
Sobolewski M, Haque M. Optimising treatment distance and treatment area for HDR surface mould brachytherapy. Australas Phys Eng Sci Med 2014; 37: 681-689.
37.
Shah C, Ouhib Z, Kamrava M et al. The American Brachytherapy society consensus statement for skin brachytherapy. Brachytherapy 2020; 19: 415-426.
38.
Fionda B, Placidi E, Rosa E et al. Multilayer intensity modulated contact interventional radiotherapy (brachytherapy): Stretching the therapeutic window in skin cancer. J Contemp Brachytherapy 2023; 15: 220-223.